Results for tag: "Torisel"

Torisel (temsirolimus) is a drug used to treat advanced metastatic renal cell carcinoma (RCC), a type of skin cancer. It is an intravenous medication that works by inhibiting the mTOR protein, which is involved in the growth and spread of cancer cells. Torisel is used in combination with other drugs to treat advanced RCC, and is approved for use in the United States, Europe, and other countries. Torisel is a relatively new drug, and is part of a class of drugs known as mTOR inhibitors. It is the only mTOR inhibitor approved for use in the United States, and is considered to be a promising treatment for advanced RCC. The Torisel market is highly competitive, with several companies offering similar drugs. These include Pfizer, Novartis, and Merck, among others. Each company has its own unique approach to the treatment of advanced RCC, and the market is constantly evolving as new drugs are developed and approved. Show Less Read more